The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure

Ross Arena, Jonathan Myers, Joshua Abella, Sherry Pinkstaff, Peter Brubaker, Brian Moore, Dalane Kitzman, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Marco Guazzi

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: The resting partial pressure of end-tidal carbon dioxide (Petco2) has been shown to reflect cardiac performance in acute care settings in patients with heart failure (HF). The purpose of the present study was to compare the prognostic ability of the partial pressure of Petco2 at rest to other commonly collected resting variables in patients with systolic HF. Methods: A total of 353 patients (mean age 58.6 ± 13.7, 72% male) with systolic HF were included in this study. All patients underwent cardiopulmonary exercise testing where New York Heart Association (NYHA) class, resting Petco2, peak oxygen consumption, and the minute ventilation/carbon dioxide production slope were determined. Subjects were then followed for major cardiac events (mortality, left ventricular assist device implantation implantation, urgent heart transplantation). Results: There were 104 major cardiac events during the 23.6 ± 17.0-month tracking period. Multivariate Cox regression analysis revealed NYHA class (χ2 28.7, P <.001), left ventricular ejection fraction (residual χ2 21.7, P <.001), and resting Petco2 (residual χ2 14.1, P <.001) were all prognostically significant and retained in the regression. In a separate Cox regression analysis, left ventricular ejection fraction (residual χ2 8.8, P = .003), NYHA class (residual χ2 7.7, P = .005), and resting Petco2 (residual χ2 5.7, P = .02) added prognostic value to the minute ventilation/carbon dioxide production slope (χ2 26.0, P <.001). Conclusion: Resting Petco2 can be noninvasively collected from subjects in a short period, at a low cost, and with no risk or discomfort to the patient. Given the prognostic value demonstrated in the present study, the clinical assessment of resting Petco2 in the HF population may be warranted.

Original languageEnglish
Pages (from-to)982-988
Number of pages7
JournalAmerican Heart Journal
Volume156
Issue number5
DOIs
Publication statusPublished - Nov 2008

Fingerprint

Systolic Heart Failure
Partial Pressure
Carbon Dioxide
Stroke Volume
Ventilation
Heart Failure
Regression Analysis
Heart-Assist Devices
Heart Transplantation
Oxygen Consumption
Exercise
Costs and Cost Analysis
Mortality
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. / Arena, Ross; Myers, Jonathan; Abella, Joshua; Pinkstaff, Sherry; Brubaker, Peter; Moore, Brian; Kitzman, Dalane; Peberdy, Mary Ann; Bensimhon, Daniel; Chase, Paul; Guazzi, Marco.

In: American Heart Journal, Vol. 156, No. 5, 11.2008, p. 982-988.

Research output: Contribution to journalArticle

Arena, R, Myers, J, Abella, J, Pinkstaff, S, Brubaker, P, Moore, B, Kitzman, D, Peberdy, MA, Bensimhon, D, Chase, P & Guazzi, M 2008, 'The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure', American Heart Journal, vol. 156, no. 5, pp. 982-988. https://doi.org/10.1016/j.ahj.2008.06.024
Arena, Ross ; Myers, Jonathan ; Abella, Joshua ; Pinkstaff, Sherry ; Brubaker, Peter ; Moore, Brian ; Kitzman, Dalane ; Peberdy, Mary Ann ; Bensimhon, Daniel ; Chase, Paul ; Guazzi, Marco. / The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. In: American Heart Journal. 2008 ; Vol. 156, No. 5. pp. 982-988.
@article{ad9e92e3ad0f4a8f8586192b0256fa3c,
title = "The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure",
abstract = "Background: The resting partial pressure of end-tidal carbon dioxide (Petco2) has been shown to reflect cardiac performance in acute care settings in patients with heart failure (HF). The purpose of the present study was to compare the prognostic ability of the partial pressure of Petco2 at rest to other commonly collected resting variables in patients with systolic HF. Methods: A total of 353 patients (mean age 58.6 ± 13.7, 72{\%} male) with systolic HF were included in this study. All patients underwent cardiopulmonary exercise testing where New York Heart Association (NYHA) class, resting Petco2, peak oxygen consumption, and the minute ventilation/carbon dioxide production slope were determined. Subjects were then followed for major cardiac events (mortality, left ventricular assist device implantation implantation, urgent heart transplantation). Results: There were 104 major cardiac events during the 23.6 ± 17.0-month tracking period. Multivariate Cox regression analysis revealed NYHA class (χ2 28.7, P <.001), left ventricular ejection fraction (residual χ2 21.7, P <.001), and resting Petco2 (residual χ2 14.1, P <.001) were all prognostically significant and retained in the regression. In a separate Cox regression analysis, left ventricular ejection fraction (residual χ2 8.8, P = .003), NYHA class (residual χ2 7.7, P = .005), and resting Petco2 (residual χ2 5.7, P = .02) added prognostic value to the minute ventilation/carbon dioxide production slope (χ2 26.0, P <.001). Conclusion: Resting Petco2 can be noninvasively collected from subjects in a short period, at a low cost, and with no risk or discomfort to the patient. Given the prognostic value demonstrated in the present study, the clinical assessment of resting Petco2 in the HF population may be warranted.",
author = "Ross Arena and Jonathan Myers and Joshua Abella and Sherry Pinkstaff and Peter Brubaker and Brian Moore and Dalane Kitzman and Peberdy, {Mary Ann} and Daniel Bensimhon and Paul Chase and Marco Guazzi",
year = "2008",
month = "11",
doi = "10.1016/j.ahj.2008.06.024",
language = "English",
volume = "156",
pages = "982--988",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure

AU - Arena, Ross

AU - Myers, Jonathan

AU - Abella, Joshua

AU - Pinkstaff, Sherry

AU - Brubaker, Peter

AU - Moore, Brian

AU - Kitzman, Dalane

AU - Peberdy, Mary Ann

AU - Bensimhon, Daniel

AU - Chase, Paul

AU - Guazzi, Marco

PY - 2008/11

Y1 - 2008/11

N2 - Background: The resting partial pressure of end-tidal carbon dioxide (Petco2) has been shown to reflect cardiac performance in acute care settings in patients with heart failure (HF). The purpose of the present study was to compare the prognostic ability of the partial pressure of Petco2 at rest to other commonly collected resting variables in patients with systolic HF. Methods: A total of 353 patients (mean age 58.6 ± 13.7, 72% male) with systolic HF were included in this study. All patients underwent cardiopulmonary exercise testing where New York Heart Association (NYHA) class, resting Petco2, peak oxygen consumption, and the minute ventilation/carbon dioxide production slope were determined. Subjects were then followed for major cardiac events (mortality, left ventricular assist device implantation implantation, urgent heart transplantation). Results: There were 104 major cardiac events during the 23.6 ± 17.0-month tracking period. Multivariate Cox regression analysis revealed NYHA class (χ2 28.7, P <.001), left ventricular ejection fraction (residual χ2 21.7, P <.001), and resting Petco2 (residual χ2 14.1, P <.001) were all prognostically significant and retained in the regression. In a separate Cox regression analysis, left ventricular ejection fraction (residual χ2 8.8, P = .003), NYHA class (residual χ2 7.7, P = .005), and resting Petco2 (residual χ2 5.7, P = .02) added prognostic value to the minute ventilation/carbon dioxide production slope (χ2 26.0, P <.001). Conclusion: Resting Petco2 can be noninvasively collected from subjects in a short period, at a low cost, and with no risk or discomfort to the patient. Given the prognostic value demonstrated in the present study, the clinical assessment of resting Petco2 in the HF population may be warranted.

AB - Background: The resting partial pressure of end-tidal carbon dioxide (Petco2) has been shown to reflect cardiac performance in acute care settings in patients with heart failure (HF). The purpose of the present study was to compare the prognostic ability of the partial pressure of Petco2 at rest to other commonly collected resting variables in patients with systolic HF. Methods: A total of 353 patients (mean age 58.6 ± 13.7, 72% male) with systolic HF were included in this study. All patients underwent cardiopulmonary exercise testing where New York Heart Association (NYHA) class, resting Petco2, peak oxygen consumption, and the minute ventilation/carbon dioxide production slope were determined. Subjects were then followed for major cardiac events (mortality, left ventricular assist device implantation implantation, urgent heart transplantation). Results: There were 104 major cardiac events during the 23.6 ± 17.0-month tracking period. Multivariate Cox regression analysis revealed NYHA class (χ2 28.7, P <.001), left ventricular ejection fraction (residual χ2 21.7, P <.001), and resting Petco2 (residual χ2 14.1, P <.001) were all prognostically significant and retained in the regression. In a separate Cox regression analysis, left ventricular ejection fraction (residual χ2 8.8, P = .003), NYHA class (residual χ2 7.7, P = .005), and resting Petco2 (residual χ2 5.7, P = .02) added prognostic value to the minute ventilation/carbon dioxide production slope (χ2 26.0, P <.001). Conclusion: Resting Petco2 can be noninvasively collected from subjects in a short period, at a low cost, and with no risk or discomfort to the patient. Given the prognostic value demonstrated in the present study, the clinical assessment of resting Petco2 in the HF population may be warranted.

UR - http://www.scopus.com/inward/record.url?scp=54449096829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54449096829&partnerID=8YFLogxK

U2 - 10.1016/j.ahj.2008.06.024

DO - 10.1016/j.ahj.2008.06.024

M3 - Article

VL - 156

SP - 982

EP - 988

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 5

ER -